Explore factors impacting RA and axSpA management, such as radiographic progression, and sex and gender differences.
Professor Lars Erik Kristensen is Head of Research at the Parker Institute in Copenhagen, Denmark, and holds an honorary doctoral position at Lund University, Sweden, and a professorship at Copenhagen University, Denmark. He received his medical degree from Copenhagen University and a PhD in Clinical Medicine from Lund University. He later specialised in internal medicine and rheumatology. Professor Kristensen also completed a postdoc at Karolinska University, Sweden.
Professor Kristensen’s research interests are degenerative and inflammatory arthritis, with a focus on patient value, lifestyle factors, treatment response and predictors thereof in randomised controlled trials and observational settings. He also managed his own research group (South Swedish Arthritis Treatment Group [SSATG]) in Lund from 2011 to 2013. Professor Kristensen is also a board member and head of research at the Danish Society of Rheumatology. He has given >250 lectures at national and international congresses and meetings.
Explore factors impacting RA and axSpA management, such as radiographic progression, and sex and gender differences.
Explore the potential implications of biologic disease-modifying antirheumatic drug (bDMARD) molecular structure on placental transfer
Empower patients with PsA with this interactive guide to help them confidently prepare for appointments and support shared decision-making
Empower patients with axSpA with this interactive guide to help them confidently prepare for appointments and support shared decision-making
Accompany Dr Ann-Sophie De Craemer as she discusses management options for a patient with axSpA exhibiting few symptoms.
Work through the challenges in diagnosing suspected axSpA in two patient cases with Dr Michael Nissen and Dr Philipp Julian Bosch.